Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
At China Biologic Products (NASDAQ:CBPO), a filing with the SEC revealed that on Thursday, Chief Executive Officer David Gao bought 5,000 shares of CBPO, at a cost of $8.93 each, for a total investment of nearly $45,000. So far Gao is in the green, up about 8.4% on their buy based on today's trading high of $9.68. Before this latest buy, Gao bought CBPO on 2 other occasions during the past year, for a total investment of $66,500 at an average of $9.50 per share.
And also on Thursday, Director Haig Bagerdjian purchased $42,900 worth of Innodata (NASDAQ:INOD), purchasing 10,000 shares at a cost of $4.29 each. Before this latest buy, Bagerdjian purchased INOD at 3 other times during the past twelve months, for a total cost of just over $176,000 at an average of $5.05 per share. Innodata is trading down about 2.1% on the day Tuesday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.